Today

Agents

Chat

Arena

Discover

More

App

Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million - LCTX News | Rallies

Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million

LCTX•2026-08-06

Q2 operating results

Aug 06 (Reuters) - Lineage Cell Therapeutics Q2 operating expenses USD 9.992 million.

Q2 net income USD 1.544 million

Related News

American Realty Investors swings to Q2 loss on higher operating expenses

ARL•2026-08-06

AMD deepens AI inference bet with Taalas deal as chip race heats up

AMD•2026-08-06

Power Solutions International Q2 FY26 net income drops 67% to USD 16.86 million; net sales fall 21% to USD 152.54 million

PSIX•2026-08-06

Flowserve director Ajay Agrawal files initial beneficial ownership statement

FLS•2026-08-06

Independent Bank Q2 FY26 net income rises 60.15% to $81.84 million

INDB•2026-08-06